Table 2.

Cox regression analysis for prediction of OS in 149 patients with low tumor burden

Variables	Univariable analysis		Multivariable analysis
	HR (95% Cl)	p value	HR (95% Cl)	p value
Age, 1 year increase	1.00 (0.98–1.03)	0.818	1.00 (0.97–1.02)	0.839
Male (vs. female)	0.77 (0.43–1.39)	0.392	0.81 (0.43–1.51)	0.503
FIB-4 index, 1 point increase	1.07 (1.02–1.13)	0.006	1.01 (0.94–1.09)	0.779
ALBI score, 1 point increase	2.41 (1.50–2.44)	<0.001	2.13 (1.13–4.00)	0.019
AFP, 1 ng/mL increase	1.00 (1.00–1.00)	0.660
HBV positive (vs. negative)	1.02 (0.59–1.75)	0.943
HCV positive (vs. negative)	1.37 (0.79–2.38)	0.261
Cirrhosis (vs. no)	1.79 (0.97–3.22)	0.063
SR versus TACE	0.54 (0.31–0.94)	0.029	0.82 (0.43–1.55)	0.532

OS, overall survival; HR, hazard ratio; Cl, confidence interval; FIB-4 index, fibrosis-4 index; ALBI score, albumin-bilirubin score; AFP, a-fetoprotein; HBV, hepatitis B virus; HCV, hepatitis C virus; SR, surgical resection; TACE, transarterial chemoembolization.